Video
Author(s):
National Association of Specialty Pharmacy (NASP) Executive Director James E. Smeeding, RPh, MBA, discusses the cost burden of long term care compared with the high cost of short term treatment with specialty drugs.
National Association of Specialty Pharmacy (NASP) Executive Director James E. Smeeding, RPh, MBA, discusses the cost burden of long term care compared with the high cost of short term treatment with specialty drugs.
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.